Enanta Pharmaceuticals Inc (ENTA) USD0.01
1.01%- This stock can be held in a
Stocks and Shares ISASell:$11.67
Buy:$11.69
Change:
$0.39
(3.45%)
$0.39
(3.45%)Market closed | Prices delayed by at least 15 minutes
Sell:$11.67
Buy:$11.69
Change:$0.39
(3.45%)
$0.39
(3.45%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 August 2024 | Scott T RottinghausOther Level A | Sell Tax related | 1,466 | $12.73 | $18,662.18 | 18,784 |
| 15 July 2024 | Scott T RottinghausOther Level A | Sell Option/Award related | 5,375 | $17.08 | $91,805.00 | 21,717 |
| 12 July 2024 | Scott T RottinghausOther Level A | Sell Regular sell transaction (market) | 2,271 | $15.04 | $34,155.84 | 21,717 |
| 11 July 2024 | Scott T RottinghausOther Level A | Sell Regular sell transaction (market) | 4,299 | $15.07 | $64,785.93 | 23,988 |
| 17 June 2024 | Tara Lynn KiefferChief Level Officer | Sell Regular sell transaction (market) | 7,266 | $12.33 | $89,589.78 | 32,341 |
| 12 February 2024 | Jay R LulyPresident/CEO | Sell Tax related | 1,584 | $12.41 | $19,657.44 | 810,609 |
| 12 February 2024 | Yat Sun OrSenior Vice President | Sell Tax related | 1,080 | $12.41 | $13,402.80 | 373,295 |
| 12 February 2024 | Paul J MellettCFO | Sell Tax related | 973 | $12.41 | $12,074.93 | 95,896 |
| 12 February 2024 | Nathaniel S GardinerSenior Vice President | Sell Tax related | 973 | $12.41 | $12,074.93 | 70,501 |
| 12 February 2024 | Tara Lynn KiefferChief Level Officer | Sell Tax related | 973 | $12.41 | $12,074.93 | 39,607 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.